HRQoL was evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 , a generic cancer questionnaire ( completed at baseline , during study treatment , at progression and post progression ) assessing various dimensions ( global health/QoL , functional status , and symptom impact ) .